HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent (current) in the face of adversity ... a new class of cardiac anti-ischaemic compounds on the horizon?

Abstract
Although a persistent component of the sodium current (INaP) was described in cardiac tissue about three decades ago, its physiological role and potential as a therapeutic target was not immediately apparent. Subsequent demonstrations that INaP is enhanced by hypoxia and ischaemia, and that Na+ influx via INaP may contribute to cellular damage, diastolic dysfunction and arrhythmias during ischaemia and reperfusion, raised interest in INaP as a target for anti-ischaemic drugs. Several agents have now been developed to clinical stages, which have INaP block as either their main action, or as a useful co-effect. In this issue of the British Journal of Pharmacology, Vacher et al. report the anti-ischaemic actions of F15845, which appears to exhibit the most selective block of INaP yet described. Its efficacy in animal models of angina raises the prospect of new, specific, INaP blockers that may represent a largely unexploited opportunity for a new class of anti-ischaemic compounds.
AuthorsDavid A Saint
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 156 Issue 2 Pg. 211-3 (Jan 2009) ISSN: 1476-5381 [Electronic] England
PMID19133984 (Publication Type: Comment, Journal Article)
Chemical References
  • 3-(3-(2-methoxyphenylthio)-2-methylpropyl)amino-3,4-dihydro-2H-1,5-benzoxathiepine
  • Benzothiepins
  • Sodium Channel Blockers
  • Sodium Channels
  • Sodium
Topics
  • Action Potentials (drug effects)
  • Angina Pectoris (drug therapy, physiopathology)
  • Animals
  • Benzothiepins (pharmacology, therapeutic use)
  • Humans
  • Ion Channel Gating
  • Myocardial Ischemia (drug therapy, physiopathology)
  • Myocardial Reperfusion Injury (drug therapy, physiopathology)
  • Patch-Clamp Techniques
  • Sodium (metabolism)
  • Sodium Channel Blockers (pharmacology, therapeutic use)
  • Sodium Channels (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: